Seeking an inpatient hospitalist. Must be board certificed/eligable in hematology. For more information contact Carol Webb at email@example.com.
Blood and Marrow Transplant (BMT) and Acute Leukemia
Dr. Joseph McGuirk is the Medical Director for the Blood and Marrow Transplant (BMT) and Acute Leukemia Site Team. He is also Division Director of HMCT. BMT procedures are life-saving treatments for patients with leukemia, lymphoma, multiple myeloma and other related blood diseases. Established in 1977, the BMT program celebrated its 40th anniversary in 2017. The team has performed more than 3,700 transplants. We are the region's largest BMT & acute leukemia program, and part of the region's largest comprehensive cancer center. We are currently ranked in the Top 50 Cancer Programs by U.S. News & World Report. The team also trains Hematology Oncology Fellows, and we offer a one year BMT Fellowship Program.
The Blood and Marrow Transplant program at The University of Kansas Cancer Center continues to expand and provide more life-saving treatments.
- The BMT program performed 288 transplants in 2018.
- Performed over 1,700 photopherestreatments (a procedure for patients with graft-versus-host disease) in 2018.
- Enrolled over 100 patients on leukemia/myeloid and lymphoma/myeloma therapeutic clinical trials.
- Even while treating more patients, BMT staff continued to provide excellent care.
- Offer CAR T-Cell Commercial Products and Clinical Trials
"The success we continue to achieve with the BMT program is due to our outstanding physicians, clinical staff and support staff," said Joseph McGuirk, DO, BMT medical director. "Working as a team, we are able to save more lives every day."
Learn more about different hematologic cancers and treatments:
There are many clinical trials at the University of Kansas Cancer Center. Please select the links below to learn more.
Contact our Clinical Trial Nurse Navigator: